These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2833104)

  • 21. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pelvic Castleman's disease: apropos of a case].
    Calvo Villas JM; Queizán JA; López Elzaurdia C; Olivier C; Pardal E; Hernández Martín JM
    Sangre (Barc); 1996 Jun; 41(3):241-3. PubMed ID: 8755212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique presentation of Epstein-Barr virus-associated Castleman's disease.
    Gomes H; Huyett P; Laver N; Wein RO
    Am J Otolaryngol; 2013; 34(3):262-4. PubMed ID: 23394816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern.
    Dargent JL; Lespagnard L; Sirtaine N; Cantinieaux B; Li R; Hermans P
    APMIS; 2007 Jul; 115(7):869-74. PubMed ID: 17614857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extralymphonodal Castleman's disease. A case report.
    Malaguarnera M; Restuccia N; Laurino A; Lo Manto PC; Vinci E; Pistone G
    Panminerva Med; 1999 Dec; 41(4):363-6. PubMed ID: 10705721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic relapsing neuropathy associated with Castleman's disease (angiofollicular lymph node hyperplasia).
    Vingerhoets F; Kuntzer T; Delacrétaz ; Steck AJ; Knecht H; Bogousslavsky J; Meier C; Regli F
    Eur Neurol; 1995; 35(6):336-40. PubMed ID: 8591800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient.
    Gaitonde S; Vidanovic V; Ni H
    Histopathology; 2007 Jun; 50(7):954-8. PubMed ID: 17543090
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Serizawa H; Abe K; Mikata A; Toyama K
    Am J Clin Pathol; 1994 Mar; 101(3):290-5. PubMed ID: 8135184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature.
    De Marchi G; De Vita S; Fabris M; Scott CA; Ferraccioli G
    Haematologica; 2004 Apr; 89(4):ECR03. PubMed ID: 15075095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Castleman's disease, intermediate type: a case report.
    Raphael V; Lyngdoh RH
    Indian J Pathol Microbiol; 2006 Oct; 49(4):603-4. PubMed ID: 17183872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Castleman's disease: atypical manifestation in an 11-year-old girl.
    Gidvani VK; Tyree MM; Bhowmick SK
    South Med J; 2001 Feb; 94(2):250-3. PubMed ID: 11235046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of cytogenetic abnormalities in Castleman's disease.
    Menke DM; DeWald GW
    South Med J; 2001 May; 94(5):472-4. PubMed ID: 11372793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
    Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
    Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
    Vasudev Rao T; Alkindi S; Pathare AV
    Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease).
    Corbellino M; Poirel L; Aubin JT; Paulli M; Magrini U; Bestetti G; Galli M; Parravicini C
    Clin Infect Dis; 1996 Jun; 22(6):1120-1. PubMed ID: 8783733
    [No Abstract]   [Full Text] [Related]  

  • 37. CD56-Positive cutaneous lymphoma with multicentric Castleman's disease-like systemic manifestations.
    Amo Y; Ogata F; Okabe S; Yonemoto K; Katsuoka K
    J Dermatol; 2001 Dec; 28(12):746-52. PubMed ID: 11804073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Castleman's disease.
    Palestro G; Turrini F; Pagano M; Chiusa L
    Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal manifestations in Castleman's disease.
    Wengrower D; Libson E; Okon E; Goldin E
    Am J Gastroenterol; 1990 Sep; 85(9):1179-81. PubMed ID: 2389730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Siltuximab: a new option for the management of Castleman's disease.
    Barquero N
    Drugs Today (Barc); 2015 Jan; 51(1):21-8. PubMed ID: 25685858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.